These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 169651)

  • 21. Development and characterization of monoclonal antibodies to foot and mouth disease virus type 'C'.
    Saha SN; Natarajan C
    Indian J Exp Biol; 1998 Dec; 36(12):1258-63. PubMed ID: 10093509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the differentiation of the foot-and-mouth disease virus types O, A and C in cell culture using the direct Coons' method].
    Kokles R; Hahnefeld E; Hahnefeld H
    Arch Exp Veterinarmed; 1968; 22(1):77-83. PubMed ID: 4176180
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the foot-and-mouth disease virus cultured on the BHK-21 cell line].
    Mitev G; Tekerlekov P
    Vet Med Nauki; 1973; 10(4):3-8. PubMed ID: 4370848
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
    Wagner GG; Cown KM
    J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle.
    Cartwright B; Chapman WG; Sharpe RT
    Res Vet Sci; 1982 May; 32(3):338-42. PubMed ID: 6179141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross reactions of normal bovine sera with foot-and-mouth disease virus: incidence, duration, and effect of shipping stress.
    Andersen AA
    Am J Vet Res; 1978 Apr; 39(4):603-6. PubMed ID: 206170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buffalo in the northern Natal game parks show no serological evidence of infection with foot-and-mouth disease virus.
    Esterhuysen JJ; Thomson GR; Flammand JR; Bengis RG
    Onderstepoort J Vet Res; 1985 Jun; 52(2):63-6. PubMed ID: 2995896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of antibody-synthesizing cells in mice and swine by means of local hemolysis in gel following immunization with foot-and-mouth disease virus and vaccine].
    Wittmann G; Reda I
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):420-5. PubMed ID: 4154623
    [No Abstract]   [Full Text] [Related]  

  • 30. Foot-and-mouth disease virus: plaque reduction neutralization tests.
    McVicar JW; Sutmoller P; Andersen AA
    Arch Gesamte Virusforsch; 1974; 44(2):168-72. PubMed ID: 4365185
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of foot-and-mouth disease virus antibody using counterimmunoelectrophoresis and serum neutralisation tests.
    Rao MV; Suryanarayana VV; Bhanumati N; Rao DR; Madhusudan P; Rao BU
    Trop Anim Health Prod; 1985 May; 17(2):89-92. PubMed ID: 2992139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localisation on foot-and-mouth disease virus (FMDV) of an antigenic deficiency induced by passage in BHK cells.
    Meloen RH
    Arch Virol; 1976; 51(4):299-306. PubMed ID: 184763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of foot-and-mouth disease virus strains by complement fixation. I. A model for the fixation of complement by antigen-antibody mixtures.
    Forman AJ
    J Hyg (Lond); 1974 Jun; 72(3):397-405. PubMed ID: 4367223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of foot-and-mouth disease virus. II. Further parameters related to the sensitization of the 140S virion by antibody.
    Hardy MM; Moore DM
    J Gen Virol; 1982 Oct; 62 (Pt 2)():287-95. PubMed ID: 6292352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foot-and-mouth disease virus antibodies: comparison of a tissue culture microneutralization test with the assay in suckling mice.
    Wagner GG; McVicar JW
    Appl Microbiol; 1970 Dec; 20(6):995-7. PubMed ID: 4321714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction.
    Rweyemamu MM; Ouldridge EJ; Head M; Ferrari R
    J Biol Stand; 1984 Jul; 12(3):295-303. PubMed ID: 6090465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An international collaborative study on foot and mouth disease virus assay methods. 1. Virus infectivity and neutralizing antibody assays.
    Mowat GN
    J Biol Stand; 1984 Oct; 12(4):399-411. PubMed ID: 6098584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foot-and-mouth disease virus: rapid assay using the fluorescent antibody technique.
    Mohanty GC; Cottral GE
    Arch Gesamte Virusforsch; 1970; 32(4):348-58. PubMed ID: 4322849
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrastructural and replicative features of foot-and-mouth disease virus in persistently infected BHK-21 cells.
    Donn A; Castagnaro M; Donaldson AI
    Arch Virol; 1995; 140(1):13-25. PubMed ID: 7646338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of foot-and-mouth disease virus: further studies on plaque formation by two plaque-size variants.
    Martinsen JS
    Can J Comp Med; 1972 Jan; 36(1):26-33. PubMed ID: 4334291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.